Wenkui Fu

709 total citations · 1 hit paper
11 papers, 486 citations indexed

About

Wenkui Fu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Wenkui Fu has authored 11 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Wenkui Fu's work include RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Wenkui Fu is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Immune cells in cancer (3 papers). Wenkui Fu collaborates with scholars based in China and United States. Wenkui Fu's co-authors include Xiaorong Lin, Herui Yao, Wei Wu, Jiewen Chen, Erwei Song, Hai Hu, Man‐Li Luo, Phei Er Saw, Xiaoding Xu and Yandan Yao and has published in prestigious journals such as Nature Communications, Cancer Cell and Clinical Cancer Research.

In The Last Decade

Wenkui Fu

10 papers receiving 479 citations

Hit Papers

Cancer cell-derived arginine fuels polyamine biosynthesis... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenkui Fu China 7 275 217 138 134 54 11 486
Tomasz Adamus United States 9 248 0.9× 134 0.6× 127 0.9× 140 1.0× 55 1.0× 12 451
Maria A. Voronkova United States 9 280 1.0× 114 0.5× 119 0.9× 91 0.7× 56 1.0× 15 452
Mingming Yang China 9 264 1.0× 139 0.6× 124 0.9× 201 1.5× 68 1.3× 15 558
Lile He China 10 269 1.0× 190 0.9× 94 0.7× 63 0.5× 40 0.7× 18 432
Long Shen China 13 411 1.5× 208 1.0× 110 0.8× 236 1.8× 59 1.1× 21 683
Guanming Lu China 11 386 1.4× 330 1.5× 123 0.9× 65 0.5× 60 1.1× 27 565
Adeleh Taghikhani Iran 8 334 1.2× 191 0.9× 80 0.6× 133 1.0× 33 0.6× 8 513
Boyao Yu China 7 314 1.1× 224 1.0× 230 1.7× 165 1.2× 97 1.8× 10 585
Praneeth R. Kuninty Netherlands 9 228 0.8× 182 0.8× 194 1.4× 112 0.8× 51 0.9× 10 453

Countries citing papers authored by Wenkui Fu

Since Specialization
Citations

This map shows the geographic impact of Wenkui Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenkui Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenkui Fu more than expected).

Fields of papers citing papers by Wenkui Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenkui Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenkui Fu. The network helps show where Wenkui Fu may publish in the future.

Co-authorship network of co-authors of Wenkui Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenkui Fu. A scholar is included among the top collaborators of Wenkui Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenkui Fu. Wenkui Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhu, Yinghua, Ziwei Zhou, Xiaorong Lin, et al.. (2025). Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 43(6). 1045–1060.e7. 26 indexed citations breakdown →
2.
Zhong, Jiaxin, Junying Yuan, Wenkui Fu, et al.. (2025). Nuclear PHGDH regulates macrophage polarization through transcriptional repression of GLUD1 and GLS2 in breast cancer. Cancer Biology and Medicine. 22(5). 1–23.
3.
Zhou, Ziwei, Yinghua Zhu, Jianli Zhao, et al.. (2024). Dabrafenib upregulates hypoglycosylated MUC1 and improves the therapeutic efficacy of Tn-MUC1 CAR-T cells. Science Bulletin. 70(10). 1586–1590. 1 indexed citations
4.
Wu, Lisha, Shoumin Bai, Jing Huang, et al.. (2023). Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer. Cancers. 15(12). 3221–3221. 13 indexed citations
5.
Zhou, Ziwei, Yiming Zhao, Si Chen, et al.. (2022). Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils. Frontiers in Pharmacology. 13. 870178–870178. 37 indexed citations
6.
Li, Shouying, Haiyan Weng, Feng Zhao, et al.. (2022). Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer. Cancer Management and Research. Volume 14. 2871–2884. 1 indexed citations
7.
Zheng, Fang, Jianing Chen, Xiaoqian Zhang, et al.. (2021). The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis. Nature Communications. 12(1). 1341–1341. 133 indexed citations
8.
Li, Xiaolong & Wenkui Fu. (2021). Objective Evaluation Method of Vehicle Ride Comfort Based on Small-Sample Statistics. SAE International journal of vehicle dynamics, stability, and NVH. 5(1). 99–109. 7 indexed citations
9.
Qin, Tao, Zhuofei Bi, Huangming Hong, et al.. (2020). Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nature Communications. 11(1). 1456–1456. 137 indexed citations
10.
Nie, Yan, Hongyan Huang, Mingyan Guo, et al.. (2019). Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy. Clinical Cancer Research. 25(13). 3873–3886. 128 indexed citations
11.
Wu, Jinglai, et al.. (2013). Robust Design for Vehicle Ride Comfort and Handling with Multi-Objective Evolutionary Algorithm. SAE technical papers on CD-ROM/SAE technical paper series. 1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026